Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species
Open Access
- 1 November 2001
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (11) , 3952-3954
- https://doi.org/10.1128/jcm.39.11.3952-3954.2001
Abstract
The performance of the Etest for posaconazole (SCH 56592) susceptibility testing of 314 isolates of Candida spp. was assessed against the National Committee for Clinical Laboratory Standards (NCCLS) microdilution broth method. The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48 h at 35°C. MICs were determined by Etest for all 314 isolates with RPMI agar containing 2% glucose (RPG agar) and were read after incubation for 48 h at 35°C. The Candida isolates included C. albicans ( n = 174), C. glabrata ( n = 57), C. tropicalis ( n = 31), C. parapsilosis ( n = 39), C. krusei ( n = 5), C. guilliermondii ( n = 6), and C. lusitaniae ( n = 2). The Etest results correlated well with reference MICs. Overall agreement was 95%, and agreements for individual species were as follows: C. krusei , 100%; C. albicans , 98%; C. tropicalis , 97%; C. glabrata , 93%; C. parapsilosis , 85%; C. guilliermondii , 83%; and C. lusitaniae , 50%. The problem of trailing end points was minimized with RPG agar, and good agreement with broth dilution MICs was obtained when discernible growth within an established ellipse was ignored. The Etest method using RPG agar appears to be a useful method for determining posaconazole susceptibilities of Candida species.Keywords
This publication has 6 references indexed in Scilit:
- In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and CandidaAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast PathogensAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Susceptibilities of Candida Bloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and VoriconazoleAntimicrobial Agents and Chemotherapy, 1998
- Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin BDiagnostic Microbiology and Infectious Disease, 1998
- Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesAntimicrobial Agents and Chemotherapy, 1995
- Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazoleJournal of Antimicrobial Chemotherapy, 1995